24 March 2020 - The online platform could allow physicians to upload patient data on how malaria drugs perform on coronavirus patients.

The White House is preparing to use software provided by the technology giant Oracle to promote unproven coronavirus treatments, including a pair of malaria drugs publicized by President Trump, potentially before the government approves their use for the outbreak, according to five senior administration officials and others familiar with the plans.

An online platform designed by Oracle, in collaboration with the White House, is still taking shape, but it is likely to be used to collect information about off-label use of the drugs, chloroquine and hydroxychloroquine, which are not yet approved by the Food and Drug Administration to treat Covid-19, the disease caused by the coronavirus.

Read New York Times article